Annual Total Debt
$2.95 M
-$944.00 K-24.23%
31 December 2023
Summary:
Lineage Cell Therapeutics annual total debt is currently $2.95 million, with the most recent change of -$944.00 thousand (-24.23%) on 31 December 2023. During the last 3 years, it has fallen by -$873.00 thousand (-22.82%). LCTX annual total debt is now -42.88% below its all-time high of $5.17 million, reached on 31 December 2019.LCTX Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Debt
$2.75 M
-$201.00 K-6.81%
30 September 2024
Summary:
Lineage Cell Therapeutics quarterly total debt is currently $2.75 million, with the most recent change of -$201.00 thousand (-6.81%) on 30 September 2024. Over the past year, it has dropped by -$330.00 thousand (-10.71%). LCTX quarterly total debt is now -55.44% below its all-time high of $6.17 million, reached on 31 March 2016.LCTX Quarterly Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
LCTX Total Debt Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -24.2% | -10.7% |
| 3 y3 years | -22.8% | +1.2% |
| 5 y5 years | +30.3% | -48.2% |
LCTX Total Debt High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -24.2% | +5.3% | -29.4% | +30.9% |
| 5 y | 5 years | -42.9% | +30.3% | -48.2% | +30.9% |
| alltime | all time | -42.9% | -55.4% |
Lineage Cell Therapeutics Total Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $2.75 M(-6.8%) |
| June 2024 | - | $2.95 M(-9.3%) |
| Mar 2024 | - | $3.25 M(+10.2%) |
| Dec 2023 | $2.95 M(-24.2%) | $2.95 M(-4.2%) |
| Sept 2023 | - | $3.08 M(-9.5%) |
| June 2023 | - | $3.40 M(-6.4%) |
| Mar 2023 | - | $3.64 M(-6.6%) |
| Dec 2022 | $3.90 M(+39.0%) | $3.90 M(+39.1%) |
| Sept 2022 | - | $2.80 M(+33.3%) |
| June 2022 | - | $2.10 M(-17.9%) |
| Mar 2022 | - | $2.56 M(-8.7%) |
| Dec 2021 | $2.80 M(-26.7%) | $2.80 M(+3.1%) |
| Sept 2021 | - | $2.72 M(-6.3%) |
| June 2021 | - | $2.90 M(-18.3%) |
| Mar 2021 | - | $3.55 M(-7.1%) |
| Dec 2020 | $3.83 M(-26.0%) | $3.83 M(+34.7%) |
| Sept 2020 | - | $2.84 M(-44.3%) |
| June 2020 | - | $5.10 M(+5.6%) |
| Mar 2020 | - | $4.83 M(-6.5%) |
| Dec 2019 | $5.17 M(+128.2%) | $5.17 M(-2.7%) |
| Sept 2019 | - | $5.31 M(+9.0%) |
| June 2019 | - | $4.87 M(-4.3%) |
| Mar 2019 | - | $5.09 M(+124.8%) |
| Dec 2018 | $2.27 M(+47.7%) | $2.27 M(+38.8%) |
| Sept 2018 | - | $1.63 M(+18.6%) |
| June 2018 | - | $1.38 M(-3.9%) |
| Mar 2018 | - | $1.43 M(-6.6%) |
| Dec 2017 | $1.53 M(-61.5%) | $1.53 M(+6.5%) |
| Sept 2017 | - | $1.44 M(-64.7%) |
| June 2017 | - | $4.08 M(+9.8%) |
| Mar 2017 | - | $3.71 M(-6.8%) |
| Dec 2016 | $3.98 M(-22.0%) | $3.98 M(+24.9%) |
| Sept 2016 | - | $3.19 M(+20.3%) |
| June 2016 | - | $2.65 M(-57.1%) |
| Mar 2016 | - | $6.17 M(+20.9%) |
| Dec 2015 | $5.10 M(+868.3%) | $5.10 M(+7.4%) |
| Sept 2015 | - | $4.75 M(+30.9%) |
| June 2015 | - | $3.63 M(+350.5%) |
| Mar 2015 | - | $805.70 K(+52.9%) |
| Dec 2014 | $527.00 K(>+9900.0%) | $527.00 K(+399.1%) |
| Sept 2014 | - | $105.60 K(-8.2%) |
| June 2014 | - | $115.00 K(>+9900.0%) |
| Mar 2014 | - | $0.00(0.0%) |
| Dec 2013 | $0.00(0.0%) | $0.00(0.0%) |
| Sept 2013 | - | $0.00(0.0%) |
| June 2013 | - | $0.00(0.0%) |
| Mar 2013 | - | $0.00(0.0%) |
| Dec 2012 | $0.00(0.0%) | $0.00(0.0%) |
| Sept 2012 | - | $0.00(0.0%) |
| June 2012 | - | $0.00(0.0%) |
| Mar 2012 | - | $0.00(0.0%) |
| Dec 2011 | $0.00(0.0%) | $0.00(0.0%) |
| Sept 2011 | - | $0.00(0.0%) |
| June 2011 | - | $0.00(0.0%) |
| Mar 2011 | - | $0.00(0.0%) |
| Dec 2010 | $0.00(0.0%) | $0.00(0.0%) |
| Sept 2010 | - | $0.00(0.0%) |
| June 2010 | - | $0.00(0.0%) |
| Mar 2010 | - | $0.00(0.0%) |
| Dec 2009 | $0.00(0.0%) | $0.00(-100.0%) |
| Sept 2009 | - | $135.50 K(-95.9%) |
| June 2009 | - | $3.31 M(-5.8%) |
| Mar 2009 | - | $3.52 M(>+9900.0%) |
| Dec 2008 | $0.00 | $0.00(-100.0%) |
| Sept 2008 | - | $2.74 M(+42.6%) |
| June 2008 | - | $1.92 M(+47.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2008 | - | $1.31 M(+82.5%) |
| Dec 2007 | $716.50 K(>+9900.0%) | $716.50 K(+102.5%) |
| Sept 2007 | - | $353.90 K(+15.5%) |
| June 2007 | - | $306.40 K(+206.4%) |
| Mar 2007 | - | $100.00 K(>+9900.0%) |
| Dec 2006 | $0.00(0.0%) | $0.00(0.0%) |
| Sept 2006 | - | $0.00(0.0%) |
| June 2006 | - | $0.00(0.0%) |
| Mar 2006 | - | $0.00(0.0%) |
| Dec 2005 | $0.00(0.0%) | $0.00(0.0%) |
| Sept 2005 | - | $0.00(0.0%) |
| June 2005 | - | $0.00(0.0%) |
| Mar 2005 | - | $0.00(0.0%) |
| Dec 2004 | $0.00(-100.0%) | $0.00(0.0%) |
| Sept 2004 | - | $0.00(0.0%) |
| June 2004 | - | $0.00(0.0%) |
| Mar 2004 | - | $0.00(-100.0%) |
| Dec 2003 | $2.69 M(+23.8%) | $2.69 M(+9.4%) |
| Sept 2003 | - | $2.45 M(+9.1%) |
| June 2003 | - | $2.25 M(-2.6%) |
| Mar 2003 | - | $2.31 M(+6.5%) |
| Dec 2002 | $2.17 M(+25.3%) | $2.17 M(+6.2%) |
| Sept 2002 | - | $2.04 M(+5.9%) |
| June 2002 | - | $1.93 M(+5.7%) |
| Mar 2002 | - | $1.82 M(+5.4%) |
| Dec 2001 | $1.73 M(>+9900.0%) | $1.73 M(-48.3%) |
| Sept 2001 | - | $3.35 M(+570.0%) |
| June 2001 | - | $500.00 K(>+9900.0%) |
| Mar 2001 | - | $0.00(0.0%) |
| Dec 2000 | $0.00(0.0%) | $0.00(0.0%) |
| Sept 2000 | - | $0.00(0.0%) |
| June 2000 | - | $0.00(0.0%) |
| Mar 2000 | - | $0.00(0.0%) |
| Dec 1999 | $0.00(0.0%) | $0.00(0.0%) |
| Sept 1999 | - | $0.00(0.0%) |
| June 1999 | - | $0.00(0.0%) |
| Mar 1999 | - | $0.00(0.0%) |
| Dec 1998 | $0.00(0.0%) | - |
| Sept 1998 | - | $0.00(0.0%) |
| June 1998 | - | $0.00(0.0%) |
| June 1998 | $0.00(0.0%) | - |
| Mar 1998 | - | $0.00(0.0%) |
| Dec 1997 | - | $0.00(0.0%) |
| Sept 1997 | - | $0.00(0.0%) |
| June 1997 | $0.00(0.0%) | $0.00(0.0%) |
| Mar 1997 | - | $0.00(0.0%) |
| Dec 1996 | - | $0.00(0.0%) |
| Sept 1996 | - | $0.00(0.0%) |
| June 1996 | $0.00(0.0%) | $0.00(0.0%) |
| Mar 1996 | - | $0.00(0.0%) |
| Dec 1995 | - | $0.00(0.0%) |
| Sept 1995 | - | $0.00(0.0%) |
| June 1995 | $0.00(0.0%) | $0.00(0.0%) |
| Mar 1995 | - | $0.00(0.0%) |
| Dec 1994 | - | $0.00(0.0%) |
| Sept 1994 | - | $0.00(0.0%) |
| June 1994 | $0.00(0.0%) | $0.00(0.0%) |
| Mar 1994 | - | $0.00(0.0%) |
| Dec 1993 | - | $0.00(0.0%) |
| Sept 1993 | - | $0.00(0.0%) |
| June 1993 | $0.00(0.0%) | $0.00(0.0%) |
| Mar 1993 | - | $0.00(0.0%) |
| Dec 1992 | - | $0.00(0.0%) |
| Sept 1992 | - | $0.00(0.0%) |
| June 1992 | $0.00 | $0.00(0.0%) |
| Mar 1992 | - | $0.00 |
FAQ
- What is Lineage Cell Therapeutics annual total debt?
- What is the all time high annual total debt for Lineage Cell Therapeutics?
- What is Lineage Cell Therapeutics annual total debt year-on-year change?
- What is Lineage Cell Therapeutics quarterly total debt?
- What is the all time high quarterly total debt for Lineage Cell Therapeutics?
- What is Lineage Cell Therapeutics quarterly total debt year-on-year change?
What is Lineage Cell Therapeutics annual total debt?
The current annual total debt of LCTX is $2.95 M
What is the all time high annual total debt for Lineage Cell Therapeutics?
Lineage Cell Therapeutics all-time high annual total debt is $5.17 M
What is Lineage Cell Therapeutics annual total debt year-on-year change?
Over the past year, LCTX annual total debt has changed by -$944.00 K (-24.23%)
What is Lineage Cell Therapeutics quarterly total debt?
The current quarterly total debt of LCTX is $2.75 M
What is the all time high quarterly total debt for Lineage Cell Therapeutics?
Lineage Cell Therapeutics all-time high quarterly total debt is $6.17 M
What is Lineage Cell Therapeutics quarterly total debt year-on-year change?
Over the past year, LCTX quarterly total debt has changed by -$330.00 K (-10.71%)